ImmunityBio, Inc.
IBRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001326110
In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding ImmunityBio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 121 | 141 | +20 |
| Shares | 31.9M | 34.5M | +2.54M (+8.0%) |
| Value | $310.9M | $209.7M | −$101.3M (−32.6%) |
New holders (39)
Institutions that held ImmunityBio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (19)
Institutions that held ImmunityBio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Voloridge Investment Management, LLC | 100,022 | $974.0K |
| Glenmede Trust Co NA | 66,945 | $651.0K |
| Winning Points Advisors, LLC | 43,958 | $428.0K |
| Ameriprise Financial Inc | 27,615 | $269.0K |
| Franklin Resources Inc | 19,500 | $190.0K |
| JustInvest LLC | 15,446 | $150.0K |
| Pearl River Capital, LLC | 15,195 | $148.0K |
| Oppenheimer & Co Inc | 14,720 | $143.0K |
| Susquehanna Fundamental Investments, LLC | 13,169 | $128.0K |
| Quilter Plc | 13,116 | $128.0K |
| Penserra Capital Management LLC | 8,950 | $87.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 1,500 | $15.0K |
| O'Shaughnessy Asset Management, LLC | 1,396 | $14.0K |
| Harbour Investments, Inc. | 1,301 | $13.0K |
| Gleason Group, Inc. | 1,000 | $10.0K |
| Optimum Investment Advisors | 300 | $3.00K |
| The PNC Financial Services Group, Inc. | 250 | $2.00K |
| Kowal Investment Group, LLC | 104 | $1.00K |
| Ci Investments Inc. | 4 | $0 |